A new study using functional MRI shows the right and left hemispheres of the brain don’t communicate well in patients with an autistic condition.
A new study using functional MRI shows the right and left hemispheres of the brain don’t communicate well in patients with an autistic condition. The study is yet another in a series that suggests autism may be a disorder of connectivity. Such information could ultimately aid in the development of earlier, more effective treatments by distinguishing types of autism and allowing physicians to get to the root of the disease.
University of Utah medical researchers used fMRI to identify regions where the left and right hemispheres of the brains of autistic patients do not properly communicate with one another.
Those regions are in “hot spots” associated with functions such as motor skills, attention, facial recognition, and social functioning-all areas in which abnormal behavior is often noted in autistic patients. Scans of people without the disorder did not show the same deficits (Cerebral Cortex doi:10.1093/cercor/bhq190).
“One of the biggest problems with autism is that until recently we really didn’t understand the mechanism of the disease in the brain,” said Dr. Jeffrey Anderson, lead author of the study and a neuroradiologist at the university. “It’s hard to design treatment strategies, drugs, or other therapies if you don’t understand exactly what is wrong.”
The current study starts to show exactly what is wrong. In their investigation of 53 high-functioning male subjects with autism and 39 typically developing male subjects, the researchers found decreased interhemispheric correlations between homologous voxels in some regions of the brain in the autism sample.
The investigators constructed spatial maps of correlation between homologous voxels in each hemisphere and found significantly reduced interhemispheric correlation specific to regions relating to autistic behavior. Those areas include the: sensorimotor cortex, anterior insula, fusiform gyrus, superior temporal gyrus, and superior parietal lobe.
“Once we have hard, reproducible differences in the brain, there is so much more we can do,” said Anderson, who is also an assistant professor of radiology at the university. “We can trace these connectivity disturbances back and test what is wrong with the cells of the brain or the wiring that causes them.”
The researchers can also use the differences in connectivity to identify genes that may be abnormal.
“Ultimately we can work out the whole disease mechanism by tracing backward from known ‘hard’ abnormalities,” he said. “We have a handhold to grab onto and work with.”
If fMRI is combined with other tests, such as differences in the diffusion of water, or differences in size of brain regions, a composite test can be created to effectively classify individual patients.
“Many investigators are actively working on this right now,” Anderson said.
An autism expert from the University of California, San Francisco (UCSF) said Anderson’s research adds support to the importance of connectivity in the etiology of autism.
“We are still a long way from a diagnostic test-this research will need to be replicated-but they had a good sized sample and multiple sites were involved,” said Dr. Robert Hendren, vice chair of the psychiatry department and director of child and adolescent psychiatry at UCSF.
This study moves researchers closer to defining subtypes that may help them identify useful treatment targets, he said.
If investigators are able to diagnose autism early, it can aid treatment for the patient.
“The most effective treatments for autism right now involve adaptation strategies that are most effective if begun early,” Anderson said. “Delaying diagnosis until after a child begins school, for example, can limit options for treatment that may help a child better prepare for school, social interactions, and managing their environment at home.”
FDA Grants Expanded 510(k) Clearance for Xenoview 3T MRI Chest Coil in GE HealthCare MRI Platforms
November 21st 2024Utilized in conjunction with hyperpolarized Xenon-129 for the assessment of lung ventilation, the chest coil can now be employed in the Signa Premier and Discovery MR750 3T MRI systems.
FDA Clears AI-Powered Ultrasound Software for Cardiac Amyloidosis Detection
November 20th 2024The AI-enabled EchoGo® Amyloidosis software for echocardiography has reportedly demonstrated an 84.5 percent sensitivity rate for diagnosing cardiac amyloidosis in heart failure patients 65 years of age and older.
New Study Examines Agreement Between Radiologists and Referring Clinicians on Follow-Up Imaging
November 18th 2024Agreement on follow-up imaging was 41 percent more likely with recommendations by thoracic radiologists and 36 percent less likely on recommendations for follow-up nuclear imaging, according to new research.